|
|
Blood, 15 May 2005, Vol. 105, No. 10, pp. 3951-3955.
Prepublished online as a Blood First Edition Paper on January 18, 2005; DOI 10.1182/blood-2004-10-3927.
 Previous Article | Next Article 
Submitted October 12, 2004
Accepted January 9, 2005
Cyclosporin A and tacrolimus, but not rapamycin, inhibit MHC-restricted antigen presentation pathways in dendritic cells
Young-Ran Lee, In-Ho Yang, Young-Hee Lee, Sun-A Im, Sukgil Song, Hong Li, Kun Han, Kyungjae Kim, Seong Kug Eo, and Chong-Kil Lee*
College of Pharmacy, Chungbuk National University, Cheongju, Korea, Republic of
Department of Pharmacy, SahmYook University, Seoul, Korea, Republic of
College of Veterinary Medicine, Chonbuk National University, Chonju, Korea, Republic of
* Corresponding author; email: cklee{at}chungbuk.ac.kr.
The main targets for the immunosuppressive calcineurin inhibitors, cyclosporin A (CsA) and tacrolimus, have been considered to be activated T cells, but not antigen presenting cells. Here we demonstrate that CsA and tacrolimus, but not rapamycin, inhibit major histocompatibility complex (MHC)-restricted antigen presentation in dendritic cells (DCs). Microencapsulated ovalbumin (OVA) was efficiently captured, processed and presented on both class I MHC molecules (cross-presentation) as well as on class II MHC molecules. Addition of CsA and tacrolimus, but not rapamycin, to cultures of DCs inhibited both class I processing pathway and class II processing pathway of exogenous OVA. In addition, CsA and tacrolimus, but not rapamycin, also inhibited classical class I processing pathway of endogenous OVA. CsA and tacrolimus did not inhibit presentation of exogenously added OVA peptide, SIINFEKL, phagocytic activity of DCs, nor the total level of expression of class I MHC (H-2Kb) molecules. CsA and tacrolimus, however, inhibited profoundly the expression of SIINFEKL-H-2Kb complexes in OVA-phagocytized DCs. These results demonstrate clearly that CsA and tacrolimus inhibit intracellular processing events of antigens, and further suggest that the immunosuppressive activity of CsA and tacrolimus is at least in part due to inhibition of antigen processing pathways.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
J. B. Sacha, J. P. Giraldo-Vela, M. B. Buechler, M. A. Martins, N. J. Maness, C. Chung, L. T. Wallace, E. J. Leon, T. C. Friedrich, N. A. Wilson, et al.
Gag- and Nef-specific CD4+ T cells recognize and inhibit SIV replication in infected macrophages early after infection
PNAS,
June 16, 2009;
106(24):
9791 - 9796.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Brooks, S. P. Lee, A. M. Leese, W. A. Thomas, M. Rowe, and A. B. Rickinson
Cyclical Expression of EBV Latent Membrane Protein 1 in EBV-Transformed B Cells Underpins Heterogeneity of Epitope Presentation and CD8+ T Cell Recognition
J. Immunol.,
February 15, 2009;
182(4):
1919 - 1928.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Ohtani, S. Nagai, S. Kondo, S. Mizuno, K. Nakamura, M. Tanabe, T. Takeuchi, S. Matsuda, and S. Koyasu
Mammalian target of rapamycin and glycogen synthase kinase 3 differentially regulate lipopolysaccharide-induced interleukin-12 production in dendritic cells
Blood,
August 1, 2008;
112(3):
635 - 643.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y.-H. Lee, Y.-R. Lee, S.-A Im, S.-I. Park, K.-H. Kim, T. Gerelchuluun, S. Song, K. Kim, and C.-K. Lee
Calcineurin Inhibitors Block MHC-Restricted Antigen Presentation In Vivo
J. Immunol.,
November 1, 2007;
179(9):
5711 - 5716.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Chakraverty and M. Sykes
The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukemia
Blood,
July 1, 2007;
110(1):
9 - 17.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. D. Duncan and D. S. Wilkes
Transplant-related Immunosuppression: A Review of Immunosuppression and Pulmonary Infections
Proceedings of the ATS,
December 1, 2005;
2(5):
449 - 455.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
